Carrier-mediated transport in the hepatic distribution and elimination of drugs, with special reference to the category of organic cations
- 2 February 1990
- journal article
- review article
- Published by Springer Nature in Journal of Pharmacokinetics and Biopharmaceutics
- Vol. 18 (1), 35-70
- https://doi.org/10.1007/bf01063621
Abstract
Carrier-mediated transport of drugs occurs in various tissues in the body and may largely affect the rate of distribution and elimination. Saturable translocation mechanisms allowing competitive interactions have been identified in the kidneys (tubular secretion), mucosal cells in the gut (intestinal absorption and secretion), choroid plexus (removal of drug from the cerebrospinal fluid), and liver (hepatobiliary excretion). Drugs with quaternary and tertiary amine groups represent the large category of organic cations that can be transported via such mechanisms. The hepatic and to a lesser extent the intestinal cation carrier systems preferentially recognize relatively large molecular weight amphipathic compounds. In the case of multivalent cationic drugs, efficient transport only occurs if large hydrophobic ring structures provide a sufficient lipophilicity-hydrophilicity balance within the drug molecule. At least two separate carrier systems for hepatic uptake of organic cations have been identified through kinetic and photoaffinity labeling studies. In addition absorptive endocytosis may play a role that along with proton-antiport systems and membrane potential driven transport may lead to intracellular sequestration in lysosomes and mitochondria. Concentration gradients of inorganic ions may represent the driving forces for hepatic uptake and biliary excretion of drugs. Recent studies that aim to the identification of potential membrane carrier proteins indicate multiple carriers for organic anions, cations, and uncharged compounds with molecular weights around 50,000 Da. They may represent a family of closely related proteins exhibiting overlapping substrate specificity or, alternatively, an aspecific transport system that mediates translocation of various forms of drugs coupled with inorganic ions. Consequently, extensive pharmacokinetic interactions can be anticipated at the level of uptake and secretion of drugs regardless of their charge.This publication has 164 references indexed in Scilit:
- New Intravenous Anaesthetics and Neuromuscular Blocking DrugsDrugs, 1987
- An Assessment of StatisticsAnesthesiology, 1986
- Uptake of the neurotoxin 1-methyl-4-phenylpyridine (MPP+) by mitochondria and its relation to the inhibition of the mitochondrial oxidation of NAD+-linked substrates by MPP+Biochemical and Biophysical Research Communications, 1986
- The relation between structure and distribution of quaternary ammonium ions in mice and rats. Simple tetraalkylammonium and a series of m-substituted trimethylphenylammonium ions.Journal of Pharmacobio-Dynamics, 1986
- PHARMACOKINETICS OF VECURONIUM IN MANAnesthesiology, 1982
- Uptake of estrone, estradiol-17β and testosterone by isolated rat liver cellsBiochemical and Biophysical Research Communications, 1977
- Biopharmaceutical study of the hepato-biliary transport of drugs. V. Hepatic uptake and biliary excretion of organic cations.CHEMICAL & PHARMACEUTICAL BULLETIN, 1976
- A Scanning Electron Microscopic Study on Endothelial Cells and Kupffer Cells in Rat Liver SinusoidsArchivum histologicum japonicum, 1975
- Autoradiographic Studies on the Distribution of Quaternary Ammonium Compounds. II. Distribution of 14C-Labeled Decamethonium, Hexamethonium and Dimethonium in MiceCHEMICAL & PHARMACEUTICAL BULLETIN, 1971
- Inhibition of ouabain-H3 uptake by liver slices and its excretion into the bile and by compounds having a steroid nucleusLife Sciences, 1969